Impact of antimicrobial resistance in critically ill patients in the intensive care unit

Author:

Rodríguez Plasencia AdisnayORCID,Ortiz Vásquez Gabriela EsthefaníaORCID,Donoso Noroña Riber FabiánORCID,Gómez Martínez NairovysORCID

Abstract

According to the Pan American Health Organization, multidrug-resistant pathogens are responsible for an increase in morbidity and mortality among hospitalized patients, leading to higher healthcare costs due to the need for prescribing more expensive medications. The aim of the research was to identify, through literature review, the impact of antimicrobial resistance in Intensive Care Units. The bibliographic review study employed a qualitative methodology; its scope was explanatory, and it utilized the historical-logical method for theoretical knowledge acquisition. For empirical knowledge, documentary analysis was used, including publications found in databases such as Scielo, PubMed, Lilacs, Dialnet, Redalyc, Google Scholar, Elsevier, institutional repositories, among others. It was evidenced that the direct causes of death and bacterial resistance in the Intensive Care Unit are sepsis, followed by septic shock, the multi-organ dysfunction syndrome, and some of the antimicrobials currently used in ICUs, such as Piperacillin-Tazobactam, Cefepime, Amikacin, Cefotaxime, and the germs that showed resistance to these antimicrobials, firstly identified were Enterobacter Aerogenes, Escherichia coli, Staphylococcus Aureus. It is concluded that, in terms of the incidence of healthcare-associated infections, there is a significant impact on the health system, increasing the morbidity and mortality of the patient by up to 50 %, including longer hospital stays, greater use of antibiotics, worse prognosis, higher complication rates, and even death

Publisher

Salud, Ciencia y Tecnologia

Reference24 articles.

1. 1. Salud OM. sitio web mundial OMS. [internet]. 2020 [citado 20 sep 2022. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/antimicrobial-resistance.

2. 2. Oromì J. Importancia y limitaciones de la utilización de los antimicrobianos. medicina integral. Medicina Integral. 2000; 36 (9.):321-322.

3. 3. Serram A. la resistencia microbiana en el contexto actual y la importancia del conocimiento y aplicación en la política antimicrobiana. revista habanera de ciencias médicas. 2017; 16(3).

4. 4. Salud Opdl. resistencia a los antimicrobianos. Ops [internet]. 2015 [citado 20 sep. 2022. Disponible en: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=11129:amr-antimicrobial-resistance-intro&itemid=41534&lang=es#gsc.tab=0

5. 5. Salud Omdl. sitio web mundial. OMS [internet]. 2017 [citado 20 sept 2022. Disponible en: https://www.who.int/es/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3